Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics.

Heart failure reviews

Volumn 15, Issue 1, 2010, Pages 103-107

  Fayssoil, Abdallah ^a   Nardi, Olivier ^a   Orlikowski, David ^a   Annane, Djillali ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DYSTROPHIN;

BIOSYNTHESIS; CARDIOMYOPATHY; DRUG COMBINATION; DRUG EFFECT; DUCHENNE MUSCULAR DYSTROPHY; GENE THERAPY; GENETICS; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART PACING; HUMAN; METABOLISM; METHODOLOGY; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; STEM CELL TRANSPLANTATION;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOLOGICAL MARKERS; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHIES; DRUG THERAPY, COMBINATION; DYSTROPHIN; GENE THERAPY; HEART FAILURE; HUMANS; MUSCULAR DYSTROPHY, DUCHENNE; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; STEM CELL TRANSPLANTATION; VENTRICULAR FUNCTION, LEFT;

EID: 77950362202     PISSN: None     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-009-9156-8     Document Type: Review

References (38)